Higgins C B, Schmidt W
Circulation. 1978 Sep;58(3 Pt 1):512-9. doi: 10.1161/01.cir.58.3.512.
Intracoronary administration of contrast materials causes myocardial depression which is related to serveral physiochemical properties of the contrast solution. The role of variations in ambient calcium ions (Ca++) in mediating this effect was evaluated in 19 anesthetized dogs. Sodium meglumine diatrizoate caused decreases in left ventricular peak systolic pressure (LVPSP),-12.6 +/- 3.2%, and dp/dt at a left ventricular pressure (LVP) of 40 mm Hg, -14.3 +/- 4.1%. The total calcium (Cat) decreased from 10.2 +/- 0.2 to 6.5 +/- 0.2 mg%, while Ca++ decreased from 4.6 +/- 0.1 mg% to 2.3 +/- 0.7 mg%. In the presence of systemic hypocalcemia the myocardial depressant actions of this contrast materials were accentuated. Intracoronary administration of contrast material with added Ca++, calcium sodium meglumine metrizoate, caused no myocardial depression. Total calcium decreased only slightly (10.2 +/- 0.2 to 9.1 +/- 0.2 mg%), while Ca++ increased (4.8 +/- 0.1 to 5.1 +/- 0.2 mg%. During systemic hypocalcemia, the calcium metrizoate compound induced increases in LVPSP and dp/dt/LBP40. Thus, contrast materials caused myocardial depression which, at least in part, was related to reduction of ambient calcium through a dilutional and binding action. The addition of Ca++ to monomeric contrast materials reversed the myocardial depressant action and produced a transient rise in ambient Ca++.
冠状动脉内注射造影剂会导致心肌抑制,这与造影剂溶液的几种理化性质有关。在19只麻醉犬中评估了环境钙离子(Ca++)变化在介导这种效应中的作用。泛影葡胺钠导致左心室收缩压峰值(LVPSP)降低,降低了-12.6±3.2%,在左心室压力(LVP)为40mmHg时dp/dt降低了-14.3±4.1%。总钙(Cat)从10.2±0.2mg%降至6.5±0.2mg%,而Ca++从4.6±0.1mg%降至2.3±0.7mg%。在全身性低钙血症的情况下,这种造影剂的心肌抑制作用会增强。冠状动脉内注射添加了Ca++的造影剂(葡甲胺钙)不会引起心肌抑制。总钙仅略有下降(从10.2±0.2mg%降至9.1±0.2mg%),而Ca++升高(从4.8±0.1mg%升至5.1±0.2mg%)。在全身性低钙血症期间,葡甲胺钙化合物会使LVPSP和dp/dt/LBP40升高。因此,造影剂会导致心肌抑制,至少部分原因是通过稀释和结合作用使环境钙减少。向单体造影剂中添加Ca++可逆转心肌抑制作用,并使环境Ca++短暂升高。